<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37263559</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>07</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-2933</ISSN><JournalIssue CitedMedium="Internet"><Volume>118</Volume><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Clinical biochemistry</Title><ISOAbbreviation>Clin Biochem</ISOAbbreviation></Journal><ArticleTitle>Liver transaminase concentrations in children with acute SARS-CoV-2 infection.</ArticleTitle><Pagination><StartPage>110588</StartPage><MedlinePgn>110588</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.clinbiochem.2023.110588</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0009-9120(23)00107-8</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To evaluate the relationship between SARS-CoV-2 infection and liver injury by comparing transaminase concentrations among children tested for SARS-CoV-2 and other respiratory viruses in pediatric emergency departments.</AbstractText><AbstractText Label="DESIGN &amp; METHODS" NlmCategory="METHODS">Eligible children were &lt;18 years with suspected SARS-CoV-2, tested using molecular approaches in emergency departments between March 7, 2020, and June 15, 2021 (Pediatric Emergency Research Network), and between August 6, 2020, and February 22, 2022 (Pediatric Emergency Research Canada). We compared aspartate (AST) and alanine aminotransferase (ALT) concentrations at presentation for SARS-CoV-2 and other respiratory viruses through a multivariate linear regression model, with the natural log of serum transaminase concentrations as dependent variables.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 16,892 enrolled children, 2,462 (14.6%) had transaminase concentrations measured; 4318 (25.6%) were SARS-CoV-2 positive, and 3932 (23.3%) were tested for additional respiratory viruses. Among study participants who had additional respiratory virus testing performed, the most frequently identified viruses were enterovirus/rhinovirus [8.7% (343/3,932)], respiratory syncytial virus [4.6% (181/3,932)], and adenovirus [2.6% (103/3,932)]. Transaminase concentrations were elevated in 25.6% (54/211) of children with isolated SARS-CoV-2 detection and 21.6% (117/541) of those with no virus isolated; P = 0.25. In the multivariable model, isolated SARS-CoV-2 detection was not associated with elevated ALT (adjusted geometric mean ratio (IU/L): 0.96; 95%Confidence Interval (CI): 0.84, 1.08) or AST (adjusted geometric mean ratio (IU/L): 1.03; 95%CI: 0.92, 1.16) concentrations, with negative respiratory panel as the referent group. Ninety-day follow-up was completed in 82.2% (3,550/4,318) of SARS-CoV-2 positive children; no cases of new-onset liver disease were reported.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Among those tested, transaminase concentrations did not vary between SARS-CoV-2-positive children and those with a negative respiratory viral panel. In multivariate analysis, SARS-CoV-2 infection was not associated with increased initial transaminase concentrations compared to other respiratory viruses.</AbstractText><CopyrightInformation>Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sumner</LastName><ForeName>Madeleine W</ForeName><Initials>MW</Initials><AffiliationInfo><Affiliation>Schulich School of Medicine and Dentistry, Western University, London, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Florin</LastName><ForeName>Todd A</ForeName><Initials>TA</Initials><AffiliationInfo><Affiliation>Division of Emergency Medicine, Ann and Robert H. Lurie Children's Hospital of Chicago, Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuppermann</LastName><ForeName>Nathan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Departments of Emergency Medicine and Pediatrics, UC Davis School of Medicine and UC Davis Health, Sacramento, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Jianling</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Section of Pediatric Emergency Medicine, Department of Pediatrics, Cumming School of Medicine, University of Calgary, Calgary, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tancredi</LastName><ForeName>Daniel J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, UC Davis School of Medicine, Sacramento, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Freedman</LastName><ForeName>Stephen B</ForeName><Initials>SB</Initials><AffiliationInfo><Affiliation>Sections of Pediatric Emergency Medicine and Gastroenterology, Departments of Pediatrics and Emergency Medicine, Cumming School of Medicine, University of Calgary, Calgary, Canada. Electronic address: Stephen.freedman@ahs.ca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>of the Pediatric Emergency Research Network PERN, Pediatric Emergency Research Canada PERC – COVID-19 Study Teams</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin Biochem</MedlineTA><NlmUniqueID>0133660</NlmUniqueID><ISSNLinking>0009-9120</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 2.6.1.2</RegistryNumber><NameOfSubstance UI="D000410">Alanine Transaminase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008107" MajorTopicYN="Y">Liver Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000410" MajorTopicYN="N">Alanine Transaminase</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Aminotransferase</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Hepatotoxicity</Keyword><Keyword MajorTopicYN="N">Liver transaminase</Keyword><Keyword MajorTopicYN="N">Pediatric</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>5</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>7</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>2</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>1</Day><Hour>19</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37263559</ArticleId><ArticleId IdType="pmc">PMC10228160</ArticleId><ArticleId IdType="doi">10.1016/j.clinbiochem.2023.110588</ArticleId><ArticleId IdType="pii">S0009-9120(23)00107-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhou Y.H., Zheng K.I., Targher G., Byrne C.D., Zheng M.H. Abnormal liver enzymes in children and infants with COVID-19: A narrative review of case-series studies. Pediatr. Obes. 2020;15</Citation><ArticleIdList><ArticleId IdType="pubmed">32875680</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez A., Cantor A., Rudolph B., Miller J., Kogan‐Liberman D., Gao Q.i., Da Silva B., Margolis K.G., Ovchinsky N., Martinez M. Liver involvement in children with SARS-COV-2 infection: Two distinct clinical phenotypes caused by the same virus. Liver Int. 2021;41(9):2068–2075.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8251417</ArticleId><ArticleId IdType="pubmed">33826804</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkan G., Emiroglu M., Tuter Oz S.K., Emiroglu H.H., Turk Dagi H., Korez M.K. Gastrointestinal and liver manifestations in children with COVID-19 and their relationship to clinical course. Turk Arch Pediatr. 2022;57(4):413–420.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9318956</ArticleId><ArticleId IdType="pubmed">35822473</ArticleId></ArticleIdList></Reference><Reference><Citation>Kendall EK, Olaker VR, Kaelber DC, Xu R, Davis PB. Elevated liver enzymes and bilirubin following SARS-CoV-2 infection in children under 10. medRxiv 2022:2022.05.10.22274866.</Citation></Reference><Reference><Citation>Chu H., Chan J.-W., Yuen T.-T., Shuai H., Yuan S., Wang Y., Hu B., Yip C.-Y., Tsang J.-L., Huang X., Chai Y., Yang D., Hou Y., Chik K.-H., Zhang X., Fung A.-F., Tsoi H.-W., Cai J.-P., Chan W.-M., Ip J.D., Chu A.-H., Zhou J., Lung D.C., Kok K.-H., To K.-W., Tsang O.-Y., Chan K.-H., Yuen K.-Y. Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study. Lancet Microbe. 2020;1(1):e14–e23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7173822</ArticleId><ArticleId IdType="pubmed">32835326</ArticleId></ArticleIdList></Reference><Reference><Citation>Denina M., Pruccoli G., Scolfaro C., Mignone F., Zoppo M., Giraudo I., Silvestro E., Bertolotti L., Rosati S., Ramenghi U., Garazzino S. Sequelae of COVID-19 in hospitalized children: A 4-months follow-up. Pediatr. Infect. Dis. J. 2020;39(12):e458–e459.</Citation><ArticleIdList><ArticleId IdType="pubmed">33003103</ArticleId></ArticleIdList></Reference><Reference><Citation>Funk A.L., Florin T.A., Dalziel S.R., Mintegi S., Salvadori M.I., Tancredi D.J., Neuman M.I., Payne D.C., Plint A.C., Klassen T.P., Malley R., Ambroggio L., Kim K., Kuppermann N., Freedman S.B. Prospective cohort study of children with suspected SARS-CoV-2 infection presenting to paediatric emergency departments: a Paediatric Emergency Research Networks (PERN) Study Protocol. BMJ Open. 2021;11(1):e042121.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7813043</ArticleId><ArticleId IdType="pubmed">33452195</ArticleId></ArticleIdList></Reference><Reference><Citation>Stirnadel-Farrant H.A., Galwey N., Bains C., Yancey C., Hunt C.M. Children's liver chemistries vary with age and gender and require customized pediatric reference ranges. Regul. Toxicol. Pharm. 2015;73(1):349–355.</Citation><ArticleIdList><ArticleId IdType="pubmed">26190302</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamin W., Adams O., Kardos P., Matthys H., Meister N., Strassburg C.P. Liver involvement in acute respiratory infections in children and adolescents - results of a non-interventional study. Front. Pediatr. 2022;10</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9001984</ArticleId><ArticleId IdType="pubmed">35425729</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantor A., Miller J., Zachariah P., DaSilva B., Margolis K., Martinez M. Acute hepatitis is a prominent presentation of the multisystem inflammatory syndrome in children: A single-center report. Hepatology. 2020;72(5):1522–1527.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7655704</ArticleId><ArticleId IdType="pubmed">32810894</ArticleId></ArticleIdList></Reference><Reference><Citation>Dutta A., Saha C., Johnson C.S., Chalasani N. Variability in the upper limit of normal for serum alanine aminotransferase levels: a statewide study. Hepatology. 2009;50(6):1957–1962.</Citation><ArticleIdList><ArticleId IdType="pubmed">19787805</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>